CVS Health Corp.’s pharmacy benefit manager unit is hoping to launch an indication-based pricing program for cancer drugs in the second half of 2016, according to CVS VP and Head of Specialty Client Solutions Surya Singh.
Singh discussed indication-based pricing – a novel contracting strategy in which payers and manufacturers settle on different prices for different...